-
Table 1 displays the list of the ten COVEP-supported projects, including institutions, research topics, basic study designs, and study countries/settings. COVEP funded projects across five of the six WHO regions: two in the African Region, three in the Region of the Americas, two in the European Region, one in the South-East Asia Region, and two in the Western Pacific Region. Supported entities comprised academic and government institutions as well as a health research enterprise. Studies were conducted among diverse populations including children, pregnant women, and individuals with comorbidities such as hypertension, diabetes, and HIV. All projects concluded by June 2023 with the acceptance of their final reports. Due to unexpected and unavoidable shifts in pandemic epidemiology, some project protocols or research questions required adjustments, achieved through mutual agreement between the PIs and COVEP.
Institute Research topic Study design Setting Biomedical Research and Training Institute COVID-19 vaccine effectiveness in adults with co-morbidities Prospective observational cohort study Zimbabwe MLI Real-world effectiveness and determinants of effectiveness of COVID-19 vaccines Test-negative case control study Uganda Institute for Immunobiology and Human Genetic, Medical Faculty in Skopje Real-world effectiveness of COVID-19 vaccines in preventing symptomatic disease, hospitalization, and death Retrospective test-negative case-control study Republic of North Macedonia BiH Real-world effectiveness of Sinopharm COVID-19 vaccine Retrospective/prospective test-negative case-control study BiH P95 Latina SAS Real-world, brand-specific vaccine effectiveness of Chinese COVID-19 vaccines Test-negative case-control study Colombia Universidad del Desarrollo Platform for COVID-19 surveillance and evaluation of interventions in Chile Large-scale platforms of surveillance Chile Universidad de Antioquia Real-world effectiveness of SINOVAC vaccine Population-based retrospective cohort study Colombia University of Oxford Vaccination of pregnant women with CoronaVac and maternal and newborn health Longitudinal cohort study (PregVax) Indonesia University of Hong Kong COVID-19 vaccine effectiveness for the prevention of symptomatic, clinically severe and fatal COVID-19 disease Population-based observational cohort study Hong Kong SAR, China University of Hong Kong Modeling exit strategies from the COVID-19 epidemic in China Mathematical modeling study Hong Kong SAR, China Abbreviation: MLI=makerere university lung institute; BiH=institute for public health of the federation of Bosnia and Herzegovina; SAR=special administrative region; COVID-19=coronavirus disease 2019; COVEP=COVID-19 Vaccines Evaluation Program; SINOVAC=Sinovac Biotech Ltd. Table 1. Research projects supported by COVEP.
-
COVEP established an effective support system for facilitating independent international research studies during the COVID-19 pandemic. The successful completion of ten projects illustrates that COVEP could serve as a viable model for future international research initiatives. Key insights gained from the COVEP implementation are presented in Table 2, and are organized into categories of structure, relationships, and cooperative agreements.
Program aspect Key points Program structure • Steering committee with international partners playing the role of supporting, promoting, and monitoring
• Partnership with academic institutions for providing technical supportRelation to the institutions • Investigator independence for the most highly capable investigators and for maintaining the credibility of their findings
• Regular communication including periodic written reports
• Support to projects from both project and financial officersCooperative agreements • Bilingual, clear and transparent, freely-negotiated documentation
• End-to-end legal support of funded projects with a force majeure clause
• Flexibility to negotiate changes in research design and scopeAbbreviation: COVEP=COVID-19 Vaccines Evaluation Program. Table 2. Key lessons learned during the implementation of COVEP.
The steering committee, in collaboration with international partners, guided the COVEP initiative and monitored progress to ensure objectives were achieved. The diverse viewpoints offered by committee members were invaluable for the multifaceted tasks involved in COVEP. They also promoted the funding opportunities worldwide and assisted in selecting highly qualified international investigators. Additionally, partnership with Fudan University contributed technical support to all COVEP-supported projects and enhanced the breadth of assistance available to international projects.
Independence of the investigators and projects was crucial in attracting highly qualified PIs to COVEP. Such autonomy enhanced the credibility of COVEP project findings by reassuring journals and their readers that the funding source did not influence manuscript preparation or publication decisions.
COVEP cooperative agreements outlined the mutual responsibilities of the implementing institutions and China CDC. These agreements were bilingual, transparent, and resulted from free negotiations. They offered comprehensive legal support for funded projects. Given the unpredictability of the pandemic, these projects required the flexibility to request methodological changes if the research environment shifted unexpectedly. To safeguard investigators from unforeseen circumstances beyond their control, the agreements included a force majeure clause.
HTML
Citation: |